Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients

NCT06514508 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Motixafortide+G-CSF
DRUG: Placebo+G-CSF

Sponsor

Guangzhou Gloria Biosciences Co., Ltd.